| Literature DB >> 28100467 |
Bhopal Mohapatra1,2, Neha Zutshi1,3, Wei An1,4, Benjamin Goetz1, Priyanka Arya1,4, Timothy A Bielecki1, Insha Mushtaq1,3, Matthew D Storck1, Jane L Meza5, Vimla Band1,4,6, Hamid Band7,2,3,4,6.
Abstract
The ubiquitin ligases CBL and CBL-B are negative regulators of tyrosine kinase signaling with established roles in the immune system. However, their physiological roles in epithelial tissues are unknown. Here, we used MMTV-Cre-mediated Cbl gene deletion on a Cbl-b null background, as well as a tamoxifen-inducible mammary stem cell (MaSC)-specific Cbl and Cbl-b double knockout (Cbl/Cbl-b DKO) using Lgr5-EGFP-IRES-CreERT2, to demonstrate a mammary epithelial cell-autonomous requirement of CBL and CBL-B in the maintenance of MaSCs. Using a newly engineered tamoxifen-inducible Cbl and Cbl-b deletion model with a dual fluorescent reporter (Cblflox/flox; Cbl-bflox/flox; Rosa26-CreERT; mT/mG), we show that Cbl/Cbl-b DKO in mammary organoids leads to hyperactivation of AKT-mTOR signaling with depletion of MaSCs. Chemical inhibition of AKT or mTOR rescued MaSCs from Cbl/Cbl-b DKO-induced depletion. Our studies reveal a novel, cell-autonomous requirement of CBL and CBL-B in epithelial stem cell maintenance during organ development and remodeling through modulation of mTOR signaling.Entities:
Keywords: Basal cells; CBLB; Casitas B-lineage lymphoma; Lgr5; Luminal cells; Mammary gland development; Mammary stem cells; Mouse; mTOR signaling
Mesh:
Substances:
Year: 2017 PMID: 28100467 PMCID: PMC5358102 DOI: 10.1242/dev.138164
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868